SGLT2i reduces outcomes in HFmrEF and HFpEF regardless of glycemic status
This video was recorded during the EASD annual meeting 2022 in Stockholm, Sweden.
Pardeep Jhund is Professor of Cardiology and Epidemiology at the University of Glasgow and an honorary consultant cardiologist at the Queen Elizabeth University Hospital, Glasgow, UK.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.